Myasthenia gravis, a rare autoimmune condition affecting nerve conduction, is another common factor associated with ptosis.

Myasthenia gravis, a rare autoimmune condition affecting nerve conduction, is another common factor associated with ptosis. The NHS provides advice for anyone worried about eye problems ...

“It can affect the eyes, causing ptosis or hanging eyelids ... In 2016, an international guidelines consensus paper from the Myasthenia Gravis Foundation of America-appointed Task Force set two goals ...

Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular ... A 71-year-old man with a 1-year history of fluctuating right eyelid ptosis and diplopia was admitted to our hospital.

Results: Examination revealed ptosis, dysarthria, nasal speech ... The patient was diagnosed with very-late-onset myasthenia gravis (MG) in a myasthenic crisis and later required intubation and ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ...

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.